Literature DB >> 10646979

Placental site trophoblastic tumor: imaging findings.

Y Sumi1, Y Ozaki, N Shindoh, H Katayama.   

Abstract

Placental site trophoblastic tumor (PSTT) is the least common form of gestational trophoblastic disease, with only about 100 cases having been reported. Although the imaging findings of PSTT have seldom been reported, previous findings of the tumor indicate that it can be divided into two types, a hypervascular type and a relatively hypovascular type. We reported the imaging findings of these two representative types of PSTT. In the hypervascular type, massive bleeding following dilatation and curettage have been reported. When prominent vascularity of the tumor is indicated by imaging findings, dilatation and curettage should be avoided. On the other hand, uterine conservative surgery may be possible in patients with the localized hypovascular type. The main role of imaging diagnosis of PSTT is to clarify the vascularity of the tumor.

Entities:  

Mesh:

Year:  1999        PMID: 10646979

Source DB:  PubMed          Journal:  Radiat Med        ISSN: 0288-2043


  4 in total

Review 1.  Placental site trophoblastic tumor: a case report and review of the literature.

Authors:  Rita Lucas; Teresa Margarida Cunha; Filipa Batista Santos
Journal:  J Radiol Case Rep       Date:  2015-04-30

Review 2.  Placental site trophoblastic tumor.

Authors:  Nadereh Behtash; Mojgan Karimi Zarchi
Journal:  J Cancer Res Clin Oncol       Date:  2007-08-16       Impact factor: 4.553

Review 3.  Clinical and radiological correlations in patients with gestational trophoblastic disease.

Authors:  Lana de Lourdes Aguiar Lima; Raphael Câmara Medeiros Parente; Izildinha Maestá; Joffre Amim Junior; Jorge Fonte de Rezende Filho; Carlos Antonio Barbosa Montenegro; Antônio Braga
Journal:  Radiol Bras       Date:  2016 Jul-Aug

4.  Imaging and Clinical Data of Placental Site Trophoblastic Tumor: A Case Report.

Authors:  Maryam Niknejadi; Firoozeh Ahmadi; Farnaz Akhbari
Journal:  Iran J Radiol       Date:  2016-04-16       Impact factor: 0.212

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.